Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPIRE-AI: Bococizumab Autoinjector Study
NCT02458287Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jun 2015
- Primary completion
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bococizumab in hyperlipidemia, mixed dyslipidemia, sponsored by Pfizer. Started Jun 2015; status: completed.
02
Drugs
bococizumab
03
Conditions
hyperlipidemiamixed dyslipidemia
Beyond the preview
Go deeper on NCT02458287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02458287.